Temsirolimus
Torisel
Torisel (temsirolimus) is an injectable drug for the treatment of Renal Cell Carcinoma, developed by Wyeth Pharmaceuticals and approved by the FDA in late May 2007 [1].
This is an old revision of this page, as edited by JimDavis4u (talk | contribs) at 03:50, 27 July 2007. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Torisel (temsirolimus) is an injectable drug for the treatment of Renal Cell Carcinoma, developed by Wyeth Pharmaceuticals and approved by the FDA in late May 2007 [1].